(-0.06%) 5 465.91 points
(0.09%) 39 149 points
(0.15%) 17 744 points
(-0.05%) $80.79
(-5.04%) $2.62
(-0.87%) $2 310.50
(-0.29%) $28.79
(3.19%) $1 017.90
(0.35%) $0.937
(0.78%) $10.69
(0.53%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders...
Stats | |
---|---|
Dagens volum | 529 676 |
Gjennomsnittsvolum | 2.27M |
Markedsverdi | 69.76M |
EPS | $-0.680 ( Q1 | 2024-05-08 ) |
Neste inntjeningsdato | ( $-0.590 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.480 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00500 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Silverstein Christine Berni | Buy | 2 300 | Common Stock |
2024-06-18 | Silverstein Christine Berni | Buy | 10 450 | Stock Option (Right to Buy) |
2024-06-18 | Noonberg Sarah B. | Buy | 2 300 | Common Stock |
2024-06-18 | Noonberg Sarah B. | Buy | 10 450 | Stock Option (Right to Buy) |
2024-06-18 | Mayleben Timothy M | Buy | 2 300 | Common Stock |
INSIDER POWER |
---|
92.42 |
Last 98 transactions |
Buy: 2 862 017 | Sell: 91 369 |
Volum Korrelasjon
Marinus Pharmaceuticals Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
MBIO | 0.955 |
ALLR | 0.947 |
ZD | 0.938 |
APVO | 0.936 |
PERI | 0.935 |
HOFT | 0.933 |
ISSC | 0.929 |
MPAA | 0.927 |
POAI | 0.925 |
INVE | 0.921 |
10 Mest negative korrelasjoner | |
---|---|
GRIN | -0.964 |
ABIO | -0.948 |
CSTE | -0.945 |
GALT | -0.941 |
NKTR | -0.935 |
GAIA | -0.935 |
SLAM | -0.929 |
AMRK | -0.928 |
PPTA | -0.927 |
SGRP | -0.927 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Marinus Pharmaceuticals Korrelasjon - Valuta/Råvare
Marinus Pharmaceuticals Økonomi
Annual | 2023 |
Omsetning: | $30.99M |
Bruttogevinst: | $28.50M (91.98 %) |
EPS: | $-2.63 |
FY | 2023 |
Omsetning: | $30.99M |
Bruttogevinst: | $28.50M (91.98 %) |
EPS: | $-2.63 |
FY | 2022 |
Omsetning: | $25.48M |
Bruttogevinst: | $25.14M (98.67 %) |
EPS: | $-0.510 |
FY | 2021 |
Omsetning: | $15.35M |
Bruttogevinst: | $13.87M (90.37 %) |
EPS: | $-2.69 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Marinus Pharmaceuticals
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.